EMC2 (ER membrane protein complex subunit 2) is a critical subunit of the endoplasmic reticulum membrane protein complex that mediates energy-independent insertion of newly synthesized membrane proteins into the ER membrane 123456. The protein preferentially accommodates membrane proteins with weakly hydrophobic transmembrane domains or destabilizing features, including charged and aromatic residues 12. EMC2 facilitates both cotranslational insertion of multi-pass membrane proteins and post-translational insertion of tail-anchored proteins, controlling the topology of G protein-coupled receptors through N-exo oriented insertion 3. Beyond its canonical ER insertion function, EMC2 has emerged as a key driver of breast cancer progression. EMC2 is upregulated in breast cancer and correlates with shortened patient survival 78. In triple-negative breast cancer, EMC2 promotes growth by stabilizing FDFT1 (farnesyltransferase 1) through interaction with HSP90, thereby increasing cholesterol biosynthesis and reducing ferroptosis susceptibility 8. In broader breast cancer contexts, EMC2 functions as a scaffold protein recruiting USP7 to deubiquitinate ENO1, activating the PDK1/AKT/mTOR signaling cascade 7. Epigenetic studies identified EMC2 methylation changes with causal evidence linking to acute coronary syndrome risk 9, suggesting broader disease relevance beyond malignancy. EMC2 represents a promising therapeutic target for breast cancer treatment and PDK1/AKT inhibitor sensitivity.